Advertisement
Review

Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Rachel K. Toth and Noel A. Warfel
DOI: 10.1158/1535-7163.MCT-20-0535 Published January 2021

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: December 2020 to January 2022

AbstractFull-text HTMLPDF
Total2717668673

Cited By

Article Information

Volume 20, Issue 1, pp. 3-10

DOI 
https://doi.org/10.1158/1535-7163.MCT-20-0535
PubMed 
33303645
Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received June 26, 2020
  • Revision received August 24, 2020
  • Accepted October 27, 2020
  • Published first December 10, 2020.

Article Versions

Copyright & Usage 
©2020 American Association for Cancer Research.

Author Information

  1. Rachel K. Toth1 and
  2. Noel A. Warfel1,2,*
  1. 1University of Arizona Cancer Center, Tucson, Arizona.
  2. 2Department of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona.
  1. ↵*Corresponding Author:
    Noel A. Warfel, University of Arizona, 1515 N Campbell Ave, Rm 0985A, Tucson, AZ 85724. Phone: 520-626-7756; Fax: 520-626-6898; E-mail: warfelna{at}arizona.edu
View Full Text
Back to top
View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer
Rachel K. Toth and Noel A. Warfel
Mol Cancer Ther January 1 2021 (20) (1) 3-10; DOI: 10.1158/1535-7163.MCT-20-0535
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement

Related Articles

Cited By...

More in this TOC Section